Enterococcal infections: host response, therapeutic, and prophylactic possibilities.

Area of Science:

• Microbiology
• Infectious Diseases
• Vaccinology

Background:

• Enterococcus faecalis and Enterococcus faecium are increasingly isolated from hospitalized patients, exhibiting significant antibiotic resistance.
• The genetic adaptability of enterococci facilitates rapid acquisition and transfer of antibiotic resistance genes, complicating treatment options.
• Understanding enterococcal virulence mechanisms is crucial for developing alternative therapeutic and preventive strategies.

Purpose of the Study:

• To explore novel therapeutic and preventive strategies against Enterococcus infections.
• To identify potential targets for vaccine development and antibody-based therapies.
• To investigate the role of capsular polysaccharide antigens and other surface proteins in enterococcal virulence.

Main Methods:

• Characterization of a capsular polysaccharide antigen in Enterococcus.
• Identification of clinically relevant serotypes.
• Exploration of other enterococcal surface antigens and virulence factors as potential therapeutic targets.

Main Results:

• A capsular polysaccharide antigen has been identified as a target for opsonic antibodies.
• A limited number of clinically relevant serotypes exist, suggesting feasibility for vaccine development.
• Additional surface antigens, including ABC transporter proteins and aggregation substance (AS), show potential as targets for therapeutic antibodies.

Conclusions:

• Development of an enterococcal vaccine based on capsular polysaccharides could improve infection prevention and treatment.
• Enterococcal surface antigens and virulence factors represent promising targets for novel antibody-based therapies.
• Addressing antibiotic resistance in enterococci requires a multifaceted approach, including vaccine and alternative therapeutic development.